Matches 1 - 50 out of 92 1 2 >


Match Document Document Title
US20110070169 Effervescent Oral Fentanyl Dosage Form and Methods of Administering Fentanyl  
Fentanyl-containing dosage forms and methods using same are described. These dosage forms include substantially less fentanyl by weight than known oral formulation and have advantages in terms of...
US20130149253 ORAL DOSAGE FORM OF PREGABALIN  
The invention relates to oral dosage forms of pregabalin, preferably for the modified release, and to processes for producing it.
US20120064129 GASTRIC RETAINED GABAPENTIN DOSAGE FORM  
A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
US20110206621 ORAL TRANSMUCOSAL NICOTINE DOSAGE FORM  
The invention described herein relates to an oral transmucosal solid dosage form useful in treating nicotine addiction or as a nicotine substitute or replacement. By virtue of the formulation in...
US20130202698 L-ORNIDAZOLE FORMULATIONS AND THEIR APPLICATIONS IN TREATMENT OF PARASITIC INFECTIONS  
This invention relates to new methods of treating parasitic infections, such as trichomonas vaginalis infection and cecum amoeba infection, using L-enantiomer enriched ornidazole, in particular...
US20120093738 TASTE-MASKED ORAL FORMULATIONS OF INFLUENZA ANTIVIRALS  
The present invention relates to taste-masked oral formulations of influenza antivirals. The taste-masked pharmaceutical formulations for oral administration comprise one or more influenza...
US20130323177 TUMOR-TARGETING GAS-GENERATING NANOPARTICLE, METHOD FOR PREPARING THE SAME, AND TUMOR-TARGETING NANOPARTICLE FOR DRUG DELIVERY USING THE SAME  
A tumor-targeting gas-generating nanoparticle, a method for preparing same and a tumor-targeting nanoparticle for drug delivery using same relate to a tumor-targeting gas-generating nanoparticle...
US20140079646 PHARMACEUTICAL FORMULATION FOR TREATING THE UPPER DIGESTIVE TRACT  
The invention relates to an effervescent tablet for preparing a mouth rinsing solution, wherein the effervescent tablet exhibits a high release rate of budesonide. A high availability of the...
US20120058055 GASTRORENTENTIVE ORAL HIGH DOSE ZINC PREPARATIONS  
A method of providing zinc to a subject in need of treatment includes administering to the subject an effective amount of a sustained-release zinc composition.
US20110038929 ORAL CARE PET PRODUCT AND METHOD  
An effervescent composition for reducing breath odors and preventing and/or reducing plaque buildup, deposits and/or formation on the teeth of pet animals. The effervescent composition includes at...
US20120282188 COSMETIC PRODUCT  
A cosmetic product includes at least: a first anhydrous cosmetic composition including at least colouring particles that are solid at room temperature and atmospheric pressure, the particles being...
US20120282301 POROUS CALCIUM PHOSPHATE BONE MATERIAL  
Porous calcium phosphate implant compositions that approximate the chemical composition of natural bone mineral are provided. In addition to calcium phosphate, the compositions include an...
US20140030326 EFFERVESCENT FORMULATIONS COMPRISING DEXKETOPROFEN  
The present invention relates to water-soluble formulations comprising the active agent dexketoprofen and to a process for production of said formulations. The present invention also relates to...
US20150202126 FOAMING SKINCARE FORMULATIONS  
In one aspect, the present invention is directed to formulations comprising at least one pressure generating vehicle along with at least one skincare active agent in a container such that the...
US20140120039 FOAMING SKINCARE FORMULATIONS  
In one aspect, the present invention is directed to formulations comprising at least one pressure generating vehicle along with at least one skincare active agent in a container such that the...
US20140271849 Abuse Deterrent Solid Dosage Form for Immediate Release with Functional Score  
The present disclosure provides an immediate release, abuse deterrent pharmaceutical solid dosage form comprising at least one functional score. In particular, the immediate release, abuse...
US20130344005 BOLUS FOR TREATING HYPOCALCAEMIA IN RUMINANTS  
The subject of the invention is a veterinary product or a nutrition product intended in particular for the prevention and treatment of hypocalcaemia in ruminant animals. The product is in the form...
US20130164342 FORMULATIONS FOR OSTEOPOROSIS  
The present invention relates to effervescent formulations comprising genistein with an average particle size (d50) in the range of 1 to 300 μm as active agent. The present invention also relates...
US20140170200 PESTICIDE COMPOSITIONS AND PESTICIDAL PREPARATION  
Disclosed is pesticidal particulate composition of matter, the particles comprising active substances, which react upon contact inside a pest body, the reaction generating a gaseous product and/or...
US20130224304 EFFERVESCENT NUTRITIONAL AND/OR DIETARY SUPPLEMENT COMPOSITION  
An effervescent composition is provided comprising a dry, free-flowing powder comprising (a) microcapsules comprising a hollow, solid, water soluble outer shell comprising a starch, a sugar or...
US20130149359 Effervescent Mouthwash  
The present invention comprises an effervescent composition containing an antiseptically effective amount of phytochemicals, flavonoids, and/or antimicrobial agents comprising an effective amount...
US20150245606 EFFERVESCENT TABLET FOR SPRAY DRIFT REDUCTION AND METHOD OF USE  
A liquid spray additive composition comprising: 5 to 15 wt % of spray drift retardant having particle size of less than 150 micron, and an effervescent couple comprising 15 to 30 wt % acid, and 30...
US20130280176 Immediate Release Pharmaceutical Compositions with Abuse Deterrent Properties  
The present disclosure provides pharmaceutical compositions and processes for making solid dosage form pharmaceutical compositions that provide immediate release of active ingredients and have...
US20070134164 Fentanyl composition for nasal administration  
The treatment of acute pain with a sufficient dosage by intranasal administration of fentanyl results in a time to onset of action comparable to intravenous administration and a significantly...
US20110268666 NOVEL GASTRORETENTIVE DELIVERY SYSTEM  
A novel gastroretentive delivery system comprising a tablet comprising a pharmaceutical ingredient or diagnostic, which tablet comprises a gas releasing ingredient or a tandem of two gas releasing...
US20130156707 PLANT EXTRACTS MADE OF SIDERITIS AND USE THEREOF TO BOOST COGNITIVE PERFORMANCE  
The invention relates to aboveground plant parts of Sideritis ssp. or extracts produced therefrom for use to boost cognitive performance.
US20100074849 ORGANIC ACID FREE EFFERVESCENT FORMULATION  
This invention provides a tablet that effervesces and significantly warms the water that it is dissolved in. The effervescence acts to break up the tablet allowing an exothermic material to...
US20130280177 Immediate Release, Abuse Deterrent Pharmaceutical Compositions  
The present disclosure provides pharmaceutical compositions and processes for making solid dosage form pharmaceutical compositions that provide immediate release of active ingredients and have...
US20090238769 Compositions Comprising Nonionic And Zwittterionic Surfactants  
An foaming agent comprising a non-ionic surfactant, zwitterionic surfactant, and free of anionic surfactants which is suitable for use in personal care products, e.g., dentifrice compositions,...
US20130287706 STABLE EFFERVESCENT BISPHOSPHONATE FORMULATIONS WITH RAPID SOLUBILIZATION CHARACTERISTICS  
A stable effervescent tablet, granule or powder composition free from excipients that may react with an effervescing organic acid component, comprising, an effective amount of a bisphosphonate...
US20130164227 PRODUCTION METHOD AND EFFERVESCENT FORMULATIONS COMPRISING CEPHALOSPORIN AND CLAVULANIC ACID  
The present invention relates to the process for the preparation of the pharmaceutical formulations comprising a cephalosporin antibiotic and clavulanic acid or any pharmaceutically acceptable...
US20070065366 Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation  
The invention relates to a liquid, propellant-free pharmaceutical formulation in the form of ready-to-use preparation for administration by nebulisation comprising a water soluble salt of the...
US20090253101 ORAL HYGIENE COMPOSITION AND APPARATUS AND METHOD  
A method and accompanying apparatus that allows high concentrations of hydrogen peroxide for tooth whitening by use of an aerosol spray. The aerosol spray may be delivered through a mouthpiece...
US20140079647 CEFDINIR AND CEFIXIME FORMULATIONS AND USES THEREOF  
The invention features pharmaceutically acceptable salts of cefdinir, including primary, secondary, and tertiary amine salts of cefdinir, and preparation methods, and pharmaceutical compositions...
US20130017156 CEFDINIR AND CEFIXIME FORMULATIONS AND USES THEREOF  
The invention features pharmaceutically acceptable salts of cefdinir, including primary, secondary, and tertiary amine salts of cefdinir, and preparation methods, and pharmaceutical compositions...
US20080199409 Effervescent Acidified Rehydration Preparations  
An effervescent acidified rehydration preparation for administration in the drinking water of mammals and poultry includes an amount of a dry generally water soluble acidified electrolyte...
US20070248548 STABLE HYDROALCOHOLIC ORAL SPRAY FORMULATIONS AND METHODS  
Stable formulations of an active pharmaceutical agent suitable for oral spray administration for absorption by the oral mucosa and related methods of preparation and administration of active...
US20100092400 Salicylic Acid Composition  
Provided, among other things, is a delivery module for water-based salicylic acid composition comprising: an aerosol delivery system; within the aerosol delivery system, the salicylic acid...
US20120183618 MODULAR SYSTEMS FOR THE CONTROLLED RELEASE OF A SUBSTANCE WITH SPACE AND TIME CONTROL  
An innovative pharmaceutical form for controlled drug release relates to systems obtained by the assembly of individual release modules, of which the capacity to release the drug in time and in...
US20120183609 MODULAR SYSTEMS FOR THE CONTROLLED RELEASE OF A SUBSTANCE WITH SPACE AND TIME CONTROL  
An innovative pharmaceutical form for controlled drug release relates to systems obtained by the assembly of individual release modules, of which the capacity to release the drug in time and in...
US20080206155 STABLE NON-ALCOHOLIC FOAMABLE PHARMACEUTICAL EMULSION COMPOSITIONS WITH AN UNCTUOUS EMOLLIENT AND THEIR USES  
A stable non-alcoholic foamable pharmaceutical emulsion composition includes an unctuous emollient, at a concentration of about 0.5% to about 49% by weight; at least one multi-active agent; at a...
US20100021393 Pharmaceutical Compositions Comprising Effervescent Agents and Fenofibrate  
A pharmaceutical composition comprising at least one effervescent agent and a fibrate and a process for making such composition. The fibrate is fenofibrate and the effervescent agent are in a...
US20100111877 Foam disinfectant  
The invention relates to an aqueous foam disinfectant comprised of a special surfactant system, which consists of non-ionic and amphoteric surfactants, and of a synergistic disinfectant...
US20070243141 Mucosal or Cutaneous Medicinal or Hygiene System  
A mucosal or cutaneous medicinal or hygiene system, comprising (a) a gas-driven foam dispenser; and (b) a fluid composition comprising (i) as the only foaming agent one or more polysaccharides,...
US20140234228 EFFERVESCENT COMPOSITIONS CONTAINING N-ACETYLCYSTEINE  
Effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine and a method of treating acetaminophen poisoning with effervescent pharmaceutical compositions containing a...
US20130302259 EFFERVESCENT COMPOSITIONS CONTAINING N-ACETYLCYSTEINE  
Effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine and a method of treating acetaminophen poisoning with effervescent pharmaceutical compositions containing a...
US20150147279 PREPARATIONS OF EFFERVESCENT FORMULATIONS COMPRISING CEPHALOSPORIN AND USES THEREOF  
The present invention relates to a process for preparing effervescent dosage forms comprising at least one antibiotic of cephalosporin group. The present invention also relates to effervescent...
US20130028844 PREPARATIONS FOR EFFERVESCENT FORMULATIONS COMPRISING CEPHALOSPORIN AND USES THEREOF  
The present invention relates to a process for preparing effervescent dosage forms comprising at least one antibiotic of cephalosporin group. The present invention also relates to effervescent...
US20100316577 KIT COMPRISING AN ALGINATE AND A COMPLEXING AGENT IN THE FORM OF A WATER-INSOLUBLE SALT  
The present patent application relates to a keratin material coating kit comprising: a first composition comprising an aqueous phase, at least one alginic acid-based compound and at least one...
US20050255048 Sprayable formulations for the treatment of acute inflammatory skin conditions  
A topical spray or foam, methods of making the formulation, and methods of use thereof, has been developed. In one preferred embodiment, the composition includes one or more active agents and...

Matches 1 - 50 out of 92 1 2 >